Solopharm announces that members of its team have been nominated for the industry-specific Pharma Leadership Awards® 2026, a professional project where employees within the pharmaceutical market select the best specialists in the field. According to the organizers, hundreds of candidates from dozens of companies are participating in this year's voting, and the winners will be announced on May 21, 2026, at a gala ceremony in Moscow.
The Pharma Leadership Awards® is considered one of the most prominent HR and business awards in the pharmaceutical market. Its unique feature is the expert voting process from within the industry: the best executives and functional leaders are determined by representatives of the pharmaceutical community itself. The awards feature nominations for top management, marketing, sales, analytics, HR, training, procurement, and other areas.
The published list of nominees includes the following Solopharm employees:
- Mamuka Mikhelashvili – GM & C-Level
- Nikolay Alekseev – Marketing Manager / Lead
- Lydia Vasilyeva – National Sales Manager
- Tatiana Morkovkina – E-commerce
- Elena Zvyagina – Product Marketing OTC
- Alexander Trufanov – Product Marketing RX
- Victoria Ziborova – HCP Marketing
- Asmik Karapetyan – Medical Advisor
- Yulia Shulikina – Key Account Manager
- Svetlana Lyashko – Procurement
- Maria Orekhova – HR
- Svetlana Zinchenko – HR
- Valery Batkaev – Training & Development
- Svetlana Polovinko – Training & Development
- Pavel Kopasov – SFE
- Evgenia Zhalskaya – BI
- Khristina Mushtay – BI
Recognition of the Team's Expertise
The extensive presence of Solopharm on the award's shortlist reflects the company's systematic development and the high level of expertise of its team across several areas: strategic management, the commercial division, marketing, medical affairs, analytics, and personnel training and development.
Commentary from the Solopharm Press Center
«It is especially valuable to us that the nominees are determined by the professional community itself. This is a recognition of our team's daily work, their competencies, energy, and contribution to the development of the Russian pharmaceutical industry. We congratulate our colleagues on being included in the list of nominees and wish them success!» noted the Solopharm press center.
